Synergism of CAY-1 with Amphotericin B and Itraconazole

Publisher： Karger

E-ISSN： 1421-9794|52|6|285-287

ISSN： 0009-3157

Source： Chemotherapy, Vol.52, Iss.6, 2006-10, pp. : 285-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of in vitro Antifungal Activities of Amphotericin B Lipid Complex with Itraconazole against 708 Clinical Yeast Isolates and Opportunistic Moulds Determined by National Committee for Clinical Laboratory Standards Methods M27-A and M38-P

By  

Chemotherapy, Vol. 48, Iss. 5, 2002-12 ,pp. : 224-231

Karger

Access to resources Recommend Favorite

Amphotericin B Colloidal Dispersion

By  

Chemotherapy, Vol. 45, Iss. 1, 1999-07 ,pp. : 15-26

Karger

Access to resources Recommend Favorite

Safety and Efficacy of Amphotericin B Colloidal Dispersion

By  

Chemotherapy, Vol. 45, Iss. 1, 1999-07 ,pp. : 67-76

Karger

Access to resources Recommend Favorite

Amphotericin B Dose Optimization in Children with Malignant Diseases

By  

Chemotherapy, Vol. 53, Iss. 2, 2007-02 ,pp. : 142-147

Karger

Access to resources Recommend Favorite

Treatment of Visceral Leishmaniasis with Amphotericin B Colloidal Dispersion

By  

Chemotherapy, Vol. 45, Iss. 1, 1999-07 ,pp. : 54-66

Karger

Access to resources Recommend Favorite